Moxifloxacin and gatifloxacin for initial therapy of tuberculosis: a meta-analysis of randomized clinical trials

Moxifloxacin (MOX) and gatifloxacin (GAT) have exhibited promising mycobactericidal activity, and a number of clinical trials have been conducted in recent decades to compare the treatment efficacy of MOX-containing and/or GAT-containing regimens with the standard regimen. The aim of this meta-analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruan, Qiaoling, Liu, Qihui, Sun, Feng, Shao, Lingyun, Jin, Jialin, Yu, Shenglei, Ai, Jingwen, Zhang, Bingyan, Zhang, Wenhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777926/
https://www.ncbi.nlm.nih.gov/pubmed/26905025
http://dx.doi.org/10.1038/emi.2016.12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777926/
https://www.ncbi.nlm.nih.gov/pubmed/26905025
http://dx.doi.org/10.1038/emi.2016.12

Ejemplares similares